Galliano Surgical Group is an InterStim™ Center of Excellence for Fecal Incontinence, Overactive Bladder, and Non-Obstructive Urinary Retention in Florida.
The InterStim™ Center of Excellence Program recognizes physicians who demonstrate exemplary use of the InterStim™ system and a commitment to patient care for those suffering from symptoms associated with Overactive Bladder (OAB), Fecal Incontinence (FI) and Non-Obstructive Urinary Retention.
Do you plan life around the bathroom?
You're not alone.
Bladder and bowel problems like incontinence, retention, frequency/urgency, and more can disrupt your life and your confidence. Even when medications may fail, have hope: you have treatment options.
Incontinence can be a serious condition, and it's not a normal part of getting older.
1 in 6
U.S. adults experience bladder control issues.1,2
U.S. adults experience
bowel control issues.3,4
1 in 12
InterStim™ Implant for Bladder and Bowel Control
Many first-line treatments target the muscles that control bladder and bowel functions. The InterStim™ system works by targeting the nerve that signals and regulates bladder and bowel functions.5,6,7,8
This can help restore* communication of the bladder to bowel brain communication and help you return to the activities you love.
In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling). Talk with your doctor about ways to minimize these risks.
*Restoration of function is defined as a 50 percent or greater reduction in your troublesome bladder or bowel symptoms from baseline.
Meet Your Provider
Domingo E. Galliano
MD, FACS, FASCRS
Target the problem
The Medtronic InterStim™ system targets the nerves that control your bowel and bladder.5,6 This may
improve how your bowel and bladder communicate with your brain and restore* normal bowel function.5,6,7,8
Discover proven relief
The Medtronic InterStim™ system can help, even if other
treatments have failed in the past. 89% of people using the InterStim™ system experience long-term symptom relief.9‡
Try it out before deciding
Find out if the InterStim™ system will work for you through an in-office trial. This allows you to test the device and see if you like it before making a long-term commitment.
*Restoration of function is defined as a 50 percent or greater reduction in your troublesome bladder or bowel symptoms from baseline.
‡Numbers reflect completers analysis which included patients who had complete data at baseline and at annual visits. Clinical success was 69% and complete continence was 28% in the adjusted worst case analysis.
Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Your doctor or nurse will provide you with information regarding how to operate the test device and inform you of other precautions related to the evaluation and activity restrictions.
OUR LOCATION
Find the right place to start.
There's hope for bowel control issues.
Get back to less worry, and more living.
Important Safety Information
Medtronic bladder control therapy delivered by the InterStim™ system treats urinary retention (inability to completely empty the bladder) and the symptoms of overactive bladder, including urinary urge incontinence (leakage) and significant symptoms of urgency-frequency. It should be used after you have tried other treatments such as
medications and behavioral therapy and they have not worked, or you could not tolerate them. This therapy is not intended for patients with a urinary blockage.
Safety and effectiveness have not been established for pregnancy and delivery; patients under the age of 16; or for patients with neurological disease origins.
Medtronic bowel control therapy delivered by the InterStim™ system treats chronic fecal incontinence (an accident or leaking involving stool). It should be used after you have tried other treatments such as medications and dietary modifications and they have not worked, or you are not a candidate for them.
Safety and effectiveness have not been established for pregnancy and delivery; patients under the age of 18; or for patients with progressive, systemic neurological diseases.
Medtronic bladder control therapy and Medtronic bowel control therapy: You must demonstrate an appropriate response to the evaluation to be a candidate. You cannot have diathermy (deep heat treatment from electromagnetic energy) if you have an InterStim™ device.
In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, interactions with certain other devices or diagnostic equipment such as MRI, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes
described as a jolting or shocking feeling).
This therapy is not for everyone. This treatment is prescribed by your doctor. Please talk to your doctor to decide whether this therapy is right for you. Your doctor should discuss all potential benefits and risks with you. Although many patients may benefit from the use of this treatment, results may vary. For further information, please call
Medtronic at 800-328-0810 and/or consult the Medtronic website at medtronic.com.
United States Rx only. Rev 0517.
Citations
-
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-336.
-
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data, 2024. https://www.cdc.gov/nchs/nhanes/Default.aspx. Accessed January 31, 2025.
-
Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterol. 2009;137(2):512-517.
-
Ditah I, Devaki P, Luma HN et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005-2010. Clin Gastroenterol Hepatol. 2014;12:636-643.
-
Chancellor MB, Chartier-Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromod. 2000;3(1):15-26.
-
Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11-18.
-
Lundby L, Moeller A, Buntzen S, et al. Relief of fecal incontinence by sacral nerve stimulation linked to focal brain activation. Dis Colon Rectum. 2011;54(3):318-323.
-
Janssen PTJ, Komen N, Melenhorst J, et al. Sacral neuromodulation for fecal incontinence: a review of the central mechanisms of action. J Clin Gastroenterol. 2017;51(8):669-676.
-
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):234-245.